Product Information

QUETIAPINE ER 50 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.1207 per EA under NDC 50228038060. Its NADAC has been published 359 times since Oct 9, 2019.

FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE ER 50 MG TABLET

Quetiapine
$0.1207per EA

Strength

50 mg/1

NDC

50228038060

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209635

FDA Approved

11/29/2017

TE Code

AB

On Market Since

11/29/2017

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE ER 50 MG TABLET has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1207 per EA
All-time high$0.4173 (Dec 11, 2019)
All-time low$0.0912 (Apr 17, 2024)
52-week high$0.1207
52-week low$0.1082
Median price$0.1510
Average price$0.1791
Largest weekly change+37.6% (Aug 21, 2024)
Weeks tracked359
Tracking sinceOct 9, 2019

Price History

1W

+4.9%

1M

+4.9%

3M

+9.7%

6M

+9.8%

1Y

+3.9%

3Y

-23.8%

5Y

-45.7%

All

-57.6%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QUETIAPINE ER 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 50 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.1207 per EA (NDC 50228038060), effective Aug 19, 2026.

How has the price of QUETIAPINE ER 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for QUETIAPINE ER 50 MG TABLET has declined 57.6%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.

What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 50 MG TABLET?

Since Oct 9, 2019, the NADAC for QUETIAPINE ER 50 MG TABLET has ranged from a low of $0.0912 (Apr 17, 2024) to a high of $0.4173 (Dec 11, 2019), with a median of $0.1510 per EA.

Are there cheaper alternatives to QUETIAPINE ER 50 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 50 MG TAB, is $0.0282 per EA — about 77% below QUETIAPINE ER 50 MG TABLET.

Who manufactures QUETIAPINE ER 50 MG TABLET?

QUETIAPINE ER 50 MG TABLET (NDC 50228038060) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.